Tuttle Capital Management, LLC Abbott Laboratories Transaction History

Tuttle Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $945,661 - $1.03 Million	-11,555 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$72.88 - $85.0 $842,128 - $982,175	11,555 New	11,555 $972,000
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $685,575 - $828,861	-10,353 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $10,030 - $11,363	153 Added 1.5%	10,353 $749,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $620,262 - $748,272	10,200 New	10,200 $748,000

3,230

1.3B

8.71M

8.03M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.